U.S. Health Secretary Vows Aid To India In Setting Up FDA Version (India)
This article was originally published in PharmAsia News
Executive Summary
U.S. Health and Human Services Secretary Michael Leavitt said during a visit to India that the United States plans to provide technical assistance to develop a Center for Food and Drug Administration in the country. Leavitt explained that the intention is to augment India's effort to develop and equip an FDA similar to that of the U.S. He said his counterpart, Union Health Minister Anbumani Ramadoss, indicated India wanted technical advice from the United States. Leavitt also said the U.S. is interested in having an FDA liaison office in India. (Click here for more
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.